FDA Adverse Event Malfunction Summary report: N

VIBRANT SOUNDBRIDGE

MDR report key: 23802107 · Received December 15, 2025

Report

Report Number
9710014-2025-01161
Event Type
Malfunction
Date Received
December 15, 2025
Date of Event
March 29, 2024
Report Date
January 12, 2026
Manufacturer
MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
Product Code
MPV
PMA / PMN Number
P990052
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HAS BEEN EXPLANTED AND SHOULD BE RETURNED TO THE MANUFACTURER FOR EVALUATION. WHEN AVAILABLE, A DEVICE FAILURE ANALYSIS WILL BE SUBMITTED AS A FOLLOW UP REPORT.

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: BASED ON THE LIMITED INFORMATION FROM THE FIELD, A TECHNICAL DEVICE FAILURE IS ALLEGED. HOWEVER, NO FURTHER DETAILS ARE KNOWN AND THE EXPLANTED DEVICE HAS NOT BEEN RECEIVED FOR INVESTIGATION. IN ADDITION, REPORTEDLY THE USER SUFFERED FROM FUNGAL INFECTION AND CHRONIC OTITIS MEDIA IN THE RIGHT EAR. REVIEW OF THE DEVICE'S STERILIZATION RECORDS SHOW THAT THE DEVICE HAS BEEN SUBJECT TO A VALID STERILIZATION PROCESS, THUS NO AVAILABLE INFORMATION POINTS TO THE IMPLANT BEING THE SOURCE OF THE REPORTED ISSUE.

Description of Event or Problem · 0

THE USER SUFFERED FROM FUNGAL INFECTION AND CHRONIC OTITIS MEDIA IN THE RIGHT EAR. THE USER HAS BEEN RE-IMPLANTED WITH A NEW DEVICE.

Description of Event or Problem · 0

THE USER SUFFERED FROM FUNGAL INFECTION AND CHRONIC OTITIS MEDIA IN THE RIGHT EAR. IT WAS INITIALLY REPORTED THAT THE DEVICE WAS REMOVED TO CLEAR THE INFECTION, HOWEVER, AS PER ADDITIONAL INFORMATION RECEIVED, EXPLANTATION WAS RECOMMENDED BECAUSE OF AN OBSERVED DAMAGE OF THE DEVICE. IT IS NOT CLEAR WHEN OR HOW THE CONDUCTOR LINK BROKE. THE USER HAS BEEN RE-IMPLANTED AND IS HEARING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
789408 VIBRANT SOUNDBRIDGE MIDDLE EAR IMPLANT MPV MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH VORP

Patients

Seq Age Sex Outcome Treatment
1 60 YR Female Required Intervention